You are currently on the new version of our website. Access the old version .

132 Results Found

  • Article
  • Open Access
5 Citations
1,751 Views
15 Pages

Alendronate as Bioactive Coating on Titanium Surfaces: An Investigation of CaP–Alendronate Interactions

  • Ines Despotović,
  • Željka Petrović,
  • Jozefina Katić and
  • Dajana Mikić

3 June 2024

The surface modification of dental implants plays an important role in establishing a successful interaction of the implant with the surrounding tissue, as the bioactivity and osseointegration properties are strongly dependent on the physicochemical...

  • Feature Paper
  • Article
  • Open Access
22 Citations
6,654 Views
12 Pages

Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres

  • Elisa Boanini,
  • Silvia Panseri,
  • Fabiola Arroyo,
  • Monica Montesi,
  • Katia Rubini,
  • Anna Tampieri,
  • Cristian Covarrubias and
  • Adriana Bigi

26 February 2016

In this work we synthesized mesoporous bioactive glass nanospheres (nMBG) with the aim to utilize them as substrates for loading one of the most potent amino-bisphosphonates, alendronate (AL). The results of the chemical and structural characterizati...

  • Article
  • Open Access
16 Citations
4,112 Views
16 Pages

A New Insight into Coating’s Formation Mechanism Between TiO2 and Alendronate on Titanium Dental Implant

  • Željka Petrović,
  • Ankica Šarić,
  • Ines Despotović,
  • Jozefina Katić,
  • Robert Peter,
  • Mladen Petravić and
  • Marin Petković

20 July 2020

Organophosphorus compounds, like bisphosphonates, drugs for treatment and prevention of bone diseases, have been successfully applied in recent years as bioactive and osseoinductive coatings on dental implants. An integrated experimental-theoretical...

  • Article
  • Open Access
4 Citations
2,799 Views
11 Pages

Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study

  • Alejandra Villagómez Vega,
  • Jorge Iván Gámez Nava,
  • Francisco Ruiz González,
  • Misael Pérez Romero,
  • Walter Ángel Trujillo Rangel and
  • Ismael Nuño Arana

19 February 2023

Background: Postmenopausal osteoporosis is a multifactorial disease. Genetic factors play an essential role in contributing to bone mineral density (BMD) variability, which ranges from 60 to 85%. Alendronate is used as the first line of pharmacologic...

  • Article
  • Open Access
2,340 Views
12 Pages

Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin

  • Dragos Apostu,
  • Daniel Oltean-Dan,
  • Alexandru Mester,
  • Andrei Maxim,
  • Adrian Bogdan Tigu,
  • Horea Rares Ciprian Benea,
  • Dan Cosma and
  • Doina Piciu

11 August 2022

Background and Objectives: Cementless total hip arthroplasty leads to an early periprosthetic bone loss, which can impair the osseointegration process and lead to a femoral implant migration during early weight-bearing. An altered osseointegration pr...

  • Article
  • Open Access
7 Citations
2,152 Views
13 Pages

Estrogen Deficiency Impairs Osseointegration in Hypertensive Rats Even Treated with Alendronate Coated on the Implant Surface

  • Gabriel Mulinari-Santos,
  • Jaqueline Silva dos Santos,
  • Igor Lebedenco Kitagawa,
  • Fábio Roberto de Souza Batista,
  • Paulo Roberto Botacin,
  • Cristina Antoniali,
  • Paulo Noronha Lisboa-Filho and
  • Roberta Okamoto

13 September 2023

Hypertension and estrogen deficiency can affect bone metabolism and therefore increase the risk of osseointegration. Antihypertensive drugs such as losartan not only control blood pressure but also enhance bone healing. In addition, alendronate sodiu...

  • Article
  • Open Access
2 Citations
2,174 Views
16 Pages

Immobilization of Alendronate on Zirconium Phosphate Nanoplatelets

  • Anna Donnadio,
  • Geo Paul,
  • Marianna Barbalinardo,
  • Valeria Ambrogi,
  • Gabriele Pettinacci,
  • Tamara Posati,
  • Chiara Bisio,
  • Riccardo Vivani and
  • Morena Nocchetti

15 February 2023

Different amounts of sodium-alendronate (ALN) were loaded into layered zirconium phosphates of alpha and gamma type (αZP and γZP) by means of topotactic exchange reactions of phosphate with ALN. In order to extend the exchange process to...

  • Article
  • Open Access
1 Citations
2,348 Views
18 Pages

Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models

  • Ian Stoppa,
  • Chiara Dianzani,
  • Nausicaa Clemente,
  • Annalisa Bozza,
  • Valentina Bordano,
  • Sara Garelli,
  • Luigi Cangemi,
  • Umberto Dianzani and
  • Luigi Battaglia

18 February 2024

Bone is a site of distant metastases, which are a common cause of morbidity and mortality with a high socio-economic impact, for many malignant tumours. In order to engineer pharmacological therapies that are suitable for this debilitating disease, t...

  • Article
  • Open Access
9 Citations
2,628 Views
20 Pages

Surface Functionalisation of Dental Implants with a Composite Coating of Alendronate and Hydrolysed Collagen: DFT and EIS Studies

  • Željka Petrović,
  • Ankica Šarić,
  • Ines Despotović,
  • Jozefina Katić,
  • Robert Peter,
  • Mladen Petravić,
  • Mile Ivanda and
  • Marin Petković

23 July 2022

The success of the osseointegration process depends on the surface characteristics and chemical composition of dental implants. Therefore, the titanium dental implant was functionalised with a composite coating of alendronate and hydrolysed collagen,...

  • Article
  • Open Access
12 Citations
3,501 Views
18 Pages

Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model

  • Md. Rakibul Islam,
  • Jalpa Patel,
  • Patricia Ines Back,
  • Hilary Shmeeda,
  • Raja Reddy Kallem,
  • Claire Shudde,
  • Maciej Markiewski,
  • William C. Putnam,
  • Alberto A. Gabizon and
  • Ninh M. La-Beck

26 August 2023

While tumor-associated macrophages (TAM) have pro-tumoral activity, the ablation of macrophages in cancer may be undesirable since they also have anti-tumoral functions, including T cell priming and activation against tumor antigens. Alendronate is a...

  • Article
  • Open Access
13 Citations
4,709 Views
18 Pages

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients

  • Tsuen-Wei Hsu,
  • Chien-Ning Hsu,
  • Shih-Wei Wang,
  • Chiang-Chi Huang and
  • Lung-Chih Li

A correlation between impaired bone metabolism, chronic kidney disease, and cardiovascular diseases (CVD) has been suggested. This study aimed to compare the effects of denosumab and alendronate, two anti-resorptive agents, on cardiovascular and rena...

  • Article
  • Open Access
7 Citations
3,009 Views
13 Pages

Changes in the Subchondral Bone, Visfatin, and Cartilage Biomarkers after Pharmacological Treatment of Experimental Osteoarthritis with Metformin and Alendronate

  • Sevdalina Nikolova Lambova,
  • Nina Ivanovska,
  • Stela Stoyanova,
  • Lyudmila Belenska-Todorova,
  • Elenka Georgieva,
  • Tsvetelina Batsalova,
  • Dzhemal Moten,
  • Desislava Apostolova and
  • Balik Dzhambazov

Subchondral bone that has intense communication with the articular cartilage might be a potential target for pharmacological treatment in the early stages of osteoarthritis (OA). Considering the emerging data about the role of adipokines in the patho...

  • Article
  • Open Access
432 Views
19 Pages

Comparative Molecular Docking, Molecular Dynamics and Adsorption–Release Analysis of Calcium Fructoborate and Alendronate Salts on Hydroxyapatite and Hydroxyapatite–Titanium Implants

  • Diana-Maria Trasca,
  • Ion Dorin Pluta,
  • Carmen Sirbulet,
  • Renata Maria Varut,
  • Cristina Elena Singer,
  • Denisa Preoteasa and
  • George Alin Stoica

Background/Objectives: Hydroxyapatite (HAp)-based implants and HAp–titanium (HApTi) composites are widely used in orthopedic and dental applications, but their long-term success is limited by peri-implant bone loss. Local delivery of osteoactiv...

  • Article
  • Open Access
2 Citations
1,965 Views
12 Pages

Farnesyl Diphosphate Synthase Gene Associated with Loss of Bone Mass Density and Alendronate Treatment Failure in Patients with Primary Osteoporosis

  • Werbson Lima Guaraná,
  • Camilla Albertina Dantas Lima,
  • Alexandre Domingues Barbosa,
  • Sergio Crovella and
  • Paula Sandrin-Garcia

Aminobisphosphonates (NBPs) are the first-choice medication for osteoporosis (OP); NBP treatment aims at increasing bone mineral density (BMD) by inhibiting the activity of farnesyl diphosphate synthase (FDPS) enzyme in osteoclasts. Despite its effic...

  • Article
  • Open Access
2 Citations
2,869 Views
13 Pages

Biological Effect of Single or Combined Pharmacological Therapy Using Alendronate and Simvastatin on Implant Osseointegration: An In Vivo Study in Healthy and Osteoporotic Rat Models

  • Amani M. Basudan,
  • Marwa Y. Shaheen,
  • Abdurahman A. Niazy,
  • Jeroen J.J.P. van den Beucken,
  • John A. Jansen and
  • Hamdan S. Alghamdi

23 June 2020

To evaluate peri-implant bone formation following single or combined systemic administration of alendronate and simvastatin in healthy and osteoporotic rats, eighty female Wistar rats were ovariectomized (n = 40) or sham-operated (n = 40). At six wee...

  • Article
  • Open Access
14 Citations
4,124 Views
17 Pages

Alendronate/cRGD-Decorated Ultrafine Hyaluronate Dot Targeting Bone Metastasis

  • Eunsol Lee,
  • Jaeduk Park,
  • Yu Seok Youn,
  • Kyung Taek Oh,
  • Dongin Kim and
  • Eun Seong Lee

In this study, we report the hyaluronate dot (dHA) with multiligand targeting ability and a photosensitizing antitumor model drug for treating metastatic bone tumors. Here, the dHA was chemically conjugated with alendronate (ALN, as a specific ligand...

  • Article
  • Open Access
13 Citations
3,647 Views
14 Pages

The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors

  • Věra Hedvičáková,
  • Radmila Žižková,
  • Matěj Buzgo,
  • Michala Rampichová and
  • Eva Filová

16 March 2021

Bisphosphonates (BPs) are compounds resembling the pyrophosphate structure. BPs bind the mineral component of bones. During the bone resorption by osteoclasts, nitrogen-containing BPs are released and internalized, causing an inhibition of the mevalo...

  • Article
  • Open Access
22 Citations
4,268 Views
12 Pages

Multifunctional Tannic Acid-Alendronate Nanocomplexes with Antioxidant, Anti-Inflammatory, and Osteogenic Potency

  • Somang Choi,
  • Han-Saem Jo,
  • Heegyeong Song,
  • Hak-Jun Kim,
  • Jong-Keon Oh,
  • Jae-Woo Cho,
  • Kyeongsoon Park and
  • Sung-Eun Kim

13 July 2021

In the current study, we fabricated tannic acid-alendronate (TA-ALN) nanocomplexes (NPXs) via self-assembly. These TA-ALNs were characterized by dynamic light scattering, zeta potential, transmission electron microscopy, and FT-IR spectroscopy. The T...

  • Article
  • Open Access
25 Citations
3,741 Views
15 Pages

Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer

  • Nabil A. Alhakamy,
  • Osama A. A. Ahmed,
  • Usama A. Fahmy and
  • Shadab Md

Pancreatic cancer has a low survival rate and has limited therapeutic options due to the peculiarity of the tumor tissue. Cancer nanotechnology provides several opportunities to resolve such difficulties as a result of the high surface-to-volume rati...

  • Article
  • Open Access
11 Citations
3,384 Views
16 Pages

Poly(ethylene glycol)-Alendronate-Coated Magnetite Nanoparticles Do Not Alter Cardiovascular Functions and Red Blood Cells’ Properties in Hypertensive Rats

  • Viktoriia Oleksa,
  • Iveta Bernátová,
  • Vitalii Patsula,
  • Silvia Líšková,
  • Peter Bališ,
  • Jana Radošinská,
  • Andrea Mičurová,
  • Michal Kluknavský,
  • Tomáš Jasenovec and
  • Daniel Horák
  • + 2 authors

In this study, magnetite nanoparticles were prepared and coated with poly(ethylene glycol) terminated by alendronate to ensure firm binding to the iron oxide surface. Magnetic nanoparticles, designated as magnetite coated with poly(ethylene glycol)-a...

  • Article
  • Open Access
12 Citations
3,711 Views
26 Pages

Dual Modification of Porous Ca-P/PLA Composites with APTES and Alendronate Improves Their Mechanical Strength and Cytobiocompatibility towards Human Osteoblasts

  • Monika Biernat,
  • Aleksandra Szwed-Georgiou,
  • Karolina Rudnicka,
  • Przemysław Płociński,
  • Joanna Pagacz,
  • Paulina Tymowicz-Grzyb,
  • Anna Woźniak,
  • Marcin Włodarczyk,
  • Mateusz M. Urbaniak and
  • Sylwia Rodziewicz-Motowidło
  • + 3 authors

18 November 2022

Synthetic implants are used to treat large bone defects that are often unable to regenerate, for example those caused by osteoporosis. It is necessary that the materials used to manufacture them are biocompatible and resorbable. Polymer-ceramic compo...

  • Article
  • Open Access
1 Citations
2,860 Views
16 Pages

Alendronate Release from UHMWPE-Based Biomaterials in Relation to Particle Size of the GUR Powder for Manufacturing

  • Michael Seidenstuecker,
  • Julia Weber,
  • Sergio H. Latorre,
  • Brigitte Straub,
  • Ulrich Matthes,
  • Christian Friedrich,
  • Hermann O. Mayr and
  • Anke Bernstein

6 June 2019

Ultra-high molecular weight polyethylene (UHMWPE) is widely used in endoprosthetics and has been the subject of countless studies. This project investigates the dependence of alendronate (AL) release on the molecular weight of the UHMWPE used (GUR102...

  • Article
  • Open Access
16 Citations
4,387 Views
9 Pages

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis

  • Antonino Catalano,
  • Federica Bellone,
  • Domenico Santoro,
  • Peter Schwarz,
  • Agostino Gaudio,
  • Giorgio Basile,
  • Maria Carmela Sottile,
  • Sabrina Atena Stoian,
  • Francesco Corica and
  • Nunziata Morabito

31 May 2021

Vitamin D modulates bisphosphonate (BP) efficacy, but its contribution to bone mineral density (BMD) after BP discontinuation is not known. To address this topic, we performed a retrospective analysis of postmenopausal women exposed to alendronate (A...

  • Article
  • Open Access
4 Citations
3,007 Views
20 Pages

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes

  • Alberto Gabizon,
  • Hilary Shmeeda,
  • Benjamin Draper,
  • Ana Parente-Pereira,
  • John Maher,
  • Amaia Carrascal-Miniño,
  • Rafael T. M. de Rosales and
  • Ninh M. La-Beck

Encapsulation of Doxorubicin (Dox), a potent cytotoxic agent and immunogenic cell death inducer, in pegylated (Stealth) liposomes, is well known to have major pharmacologic advantages over treatment with free Dox. Reformulation of alendronate (Ald),...

  • Article
  • Open Access
31 Citations
7,886 Views
16 Pages

Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration

  • Lacramioara Ochiuz,
  • Cristian Grigoras,
  • Marcel Popa,
  • Iulian Stoleriu,
  • Corneliu Munteanu,
  • Daniel Timofte,
  • Lenuta Profire and
  • Anca Giorgiana Grigoras

The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hy...

  • Article
  • Open Access
8 Citations
3,976 Views
20 Pages

A hemiterpene, isoprene, is commercially produced from crude oil refining processes. As a result of fossil fuel depletion, isoprene production process development is gaining attention from recombinant cyanobacteria and other microbial systems for its...

  • Article
  • Open Access
2,477 Views
13 Pages

Effects of Teriparatide and Alendronate on Functional Recovery from Spinal Cord Injury and Postinjury Bone Loss

  • Shuai Wang,
  • Jingliang Zhu,
  • Yuping Feng,
  • Yuchen Hua,
  • Gangjun You,
  • Jahui Su and
  • Benchao Shi

Objectives: This study evaluated the efficacy of teriparatide (TPTD) and alendronate (ALN) in mitigating bone loss, enhancing bone structure, and facilitating motor function recovery following spinal cord injury (SCI). Methods: All the rats were allo...

  • Article
  • Open Access
38 Citations
4,578 Views
22 Pages

Formulation and Evaluation of Niosomal Alendronate Sodium Encapsulated in Polymeric Microneedles: In Vitro Studies, Stability Study and Cytotoxicity Study

  • Ahlam Zaid Alkilani,
  • Hana Abu-Zour,
  • Anas Alshishani,
  • Rana Abu-Huwaij,
  • Haneen A. Basheer and
  • Hadeel Abo-Zour

12 October 2022

The aim of this study is to design and evaluate a transdermal delivery system for alendronate sodium (ALS) loaded with nanocarrier to improve its permeability and prolong its release. This is due to its low bioavailability, potential gastrointestinal...

  • Article
  • Open Access
39 Citations
9,197 Views
16 Pages

6 November 2015

This study investigated the effect of alendronate (Aln) released from biphasic calcium phosphate (BCP) scaffolds. We evaluated the in vitro osteogenic differentiation of Aln/BCP scaffolds using MG-63 cells and the in vivo bone regenerative capability...

  • Article
  • Open Access
8 Citations
3,679 Views
11 Pages

Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy

  • Chihiro Naito,
  • Hidemasa Katsumi,
  • Kunio Yoneto,
  • Mao Omura,
  • Mayuko Nishidono,
  • Sachi Kamei,
  • Akiya Mizoguchi,
  • Ayaka Tamba,
  • Akiko Tanaka and
  • Akira Yamamoto
  • + 1 author

For efficient transdermal delivery of alendronate (ALN) for anti-osteoporotic therapy, we developed a hyaluronic acid (HA) gel sheet that was prepared simply by enhancing HA noncovalent interactions using phosphoric acid and polyhydric alcohol (propa...

  • Article
  • Open Access
39 Citations
7,724 Views
11 Pages

Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis

  • Hidemasa Katsumi,
  • Yutaro Tanaka,
  • Kaori Hitomi,
  • Shu Liu,
  • Ying-shu Quan,
  • Fumio Kamiyama,
  • Toshiyasu Sakane and
  • Akira Yamamoto

To improve the transdermal bioavailability and safety of alendronate (ALN), a nitrogen-containing bisphosphonate, we developed self-dissolving microneedle arrays (MNs), in which ALN is loaded only at the tip portion of micron-scale needles by a dip-c...

  • Article
  • Open Access
1 Citations
2,211 Views
15 Pages

Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget’s Disease of Bone with PFN1 Mutation Are Treatable by Alendronate

  • Zhu Ling,
  • Hailati Aini,
  • Shuhei Kajikawa,
  • Jumpei Shirakawa,
  • Kunikazu Tsuji,
  • Yoshinori Asou,
  • Hideyuki Koga,
  • Ichiro Sekiya,
  • Akira Nifuji and
  • Yoichi Ezura
  • + 1 author

2 October 2023

A novel osteolytic disorder due to PFN1 mutation was discovered recently as early-onset Paget’s disease of bone (PDB). Bone loss and pain in adult PDB patients have been treated using bisphosphonates. However, therapeutic strategies for this sp...

  • Article
  • Open Access
14 Citations
4,340 Views
12 Pages

Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis

  • Lyudmila Belenska-Todorova,
  • Sevdalina Nikolova Lambova,
  • Stela Stoyanova,
  • Elenka Georgieva,
  • Tsvetelina Batsalova,
  • Dzhemal Moten,
  • Desislava Kolchakova and
  • Balik Dzhambazov

Osteoarthritis (OA) is the most common degenerative joint disease causing progressive damages of the cartilage and subchondral bone, synovial inflammation, and severe pain. Despite the complex pathomorphological changes that occur in OA, the approach...

  • Systematic Review
  • Open Access
2,833 Views
12 Pages

Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review

  • Aine Jakonyte,
  • Egle Gustainyte,
  • Zygimantas Petronis,
  • Aviad Hafizov,
  • Audra Janovskiene and
  • Dainius Razukevicius

26 June 2025

Background and Objectives: Bisphosphonates (BP) like zoledronic acid (ZA) and alendronic acid (AA) are used for osteoporosis (OP) or other bone-related conditions as well as to prevent the spread of metastases and in rheumatoid arthritis treatment. H...

  • Article
  • Open Access
22 Citations
5,249 Views
10 Pages

Alendronic Acid as Ionic Liquid: New Perspective on Osteosarcoma

  • Sónia Teixeira,
  • Miguel M. Santos,
  • Maria H. Fernandes,
  • João Costa-Rodrigues and
  • Luís C. Branco

Herein the quantitative synthesis of eight new mono- and dianionic Organic Salts and Ionic Liquids (OSILs) from alendronic acid (ALN) is reported by following two distinct sustainable and straightforward methodologies, according to the type of cation...

  • Article
  • Open Access
6 Citations
3,616 Views
14 Pages

Extended bone fractures or fractures coexisting with bone disorders can lead to non-unions where surgical intervention is required. Composite drug delivery systems are being used increasingly more in order to treat such defects locally. Alendronate (...

  • Article
  • Open Access
2 Citations
2,241 Views
18 Pages

Luminescent Alendronic Acid-Conjugated Micellar Nanostructures for Potential Application in the Bone-Targeted Delivery of Cholecalciferol

  • Federica Rizzi,
  • Annamaria Panniello,
  • Roberto Comparelli,
  • Ilaria Arduino,
  • Elisabetta Fanizza,
  • Rosa Maria Iacobazzi,
  • Maria Grazia Perrone,
  • Marinella Striccoli,
  • Maria Lucia Curri and
  • Nicoletta Depalo
  • + 2 authors

Vitamin D, an essential micronutrient crucial for skeletal integrity and various non-skeletal physiological functions, exhibits limited bioavailability and stability in vivo. This study is focused on the development of polyethylene glycol (PEG)-graft...

  • Article
  • Open Access
5 Citations
5,012 Views
11 Pages

11 August 2018

The effects of formulation characteristics on acceptability are poorly understood. This study evaluated the validity and feasibility of using the Medication Acceptability Questionnaire (MAQ) to investigate factors influencing acceptability of tablet...

  • Article
  • Open Access
4 Citations
2,667 Views
14 Pages

Evaluation of Mesenchymal Stem Cells and Osteoblasts’ Adhesion and Proliferation in the Presence of HA-AL Biomaterials

  • Oana-Elena Nicolaescu,
  • Adina Turcu-Stiolica,
  • Renata-Maria Varut,
  • Andreea-Gabriela Mocanu,
  • Ionela Belu,
  • Livia Elena Sima and
  • Johny Neamtu

22 November 2019

There is an increased interest in developing biocomposite implants with high biocompatibility in order to be used as grafts or prostheses in orthopedic surgery. The purpose of the study was to determine the biocompatibility of titanium implants coate...

  • Article
  • Open Access
4 Citations
5,207 Views
11 Pages

Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study

  • Meng-Huang Wu,
  • Yu-Sheng Lin,
  • Christopher Wu,
  • Ching-Yu Lee,
  • Yi-Chia Chen,
  • Tsung-Jen Huang and
  • Jur-Shan Cheng

8 June 2021

Bisphosphonates are used as first-line treatment for the prevention of fragility fracture (FF); they act by inhibiting osteoclast-mediated bone resorption. The timing of their administration after FF surgery is controversial; thus, we compared the in...

  • Article
  • Open Access
25 Citations
3,307 Views
16 Pages

23 February 2023

Carbon nanotubes (CNTs) are applied in a drug delivery system, which can be reacted with different structures such biomolecules. Bones have vital functions and are the locations of biochemical reactions in cells that might be exposed various diseases...

  • Article
  • Open Access
34 Citations
6,401 Views
13 Pages

12 May 2017

Desalted duck egg white peptides (DPs) have been proven to promote calcium uptake in Caco-2 cells and rats treated with a calcium-deficient diet. The retinoic acid-induced bone loss model was used to evaluate the effect of DPs on calcium absorption a...

  • Article
  • Open Access
4 Citations
3,159 Views
11 Pages

Osteopenia or osteoporosis occurs frequently in alcoholics and patients with alcoholic fatty liver disease. Methoxsalen (MTS), 8-methoxypsoralen, improved osteoporosis in ovariectomized and diabetic mouse models; however, its effects on alcohol-induc...

  • Perspective
  • Open Access
1 Citations
2,483 Views
26 Pages

Metastatic endometrial cancer continues to be a common cause of death as of 2024, even after maximal use of all currently available standard treatments. To address this problem of metastatic cancer generally in 2025, the drug repurposing movement wit...

  • Article
  • Open Access
3 Citations
2,716 Views
17 Pages

15 November 2022

The highly inert surface of polyester micro- and nano- drug carriers is a challenging substrate for further modification. The presence of surface moieties suitable for macromolecule coupling is crucial in the development of targeted drug delivery sys...

  • Article
  • Open Access
19 Citations
3,436 Views
18 Pages

19 June 2023

Bisphosphonate (BP) agents have attracted much attention for their precise therapy in some skeletal maladies demonstrated by enhancing osteoclast-mediated bone resorption. In this work, the use of CAM-B3LYP/6-311+G(d,p)/LANL2DZ to estimate the suscep...

  • Article
  • Open Access
2 Citations
1,305 Views
13 Pages

Formulation and Characterization of Bone-Targeting Vancomycin-Loaded Liposomes

  • Basel Karzoun,
  • Wala’a Albenayan,
  • Shilpa Raut and
  • Eman Atef

Background: We report the successful formulation of a bone-targeted vancomycin-loaded liposomal carrier. Method: The basic liposomal structure is composed of 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and dicetyl phosphate (DCP)...

  • Case Report
  • Open Access
15 Citations
13,316 Views
12 Pages

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition

  • Mario Migliario,
  • Giovanni Mergoni,
  • Paolo Vescovi,
  • Iolanda De Martino,
  • Manuela Alessio,
  • Luca Benzi,
  • Filippo Renò and
  • Vittorio Fusco

16 March 2017

Osteonecrosis of the jaws (ONJ) in osteoporosis patients has been defined as rare, but the number of reported cases is increasing. We report a case of delayed ONJ diagnosis in a patient, who was being treated with alendronate, developing bone alterat...

  • Case Report
  • Open Access
4 Citations
2,864 Views
6 Pages

Chronic Nonbacterial Osteomyelitis of the Jaw in a 3-Year-Old Girl

  • Shigeru Makino,
  • Hideo Oshige,
  • Jun Shinozuka and
  • Shinsaku Imashuku

2 March 2023

Differential diagnosis of bacterial osteomyelitis (BOM) and chronic nonbacterial osteomyelitis (CNO) is challenging. Pediatric CNO can be diagnosed at around 10 years of age and when CNO cases involve only the jaw, it is difficult to make a diagnosis...

  • Review
  • Open Access
23 Citations
7,719 Views
21 Pages

19 January 2012

Bone-seeking (osteotropic) drug delivery systems (ODDS) represent an interesting solution for targeting different types of drugs to the bones. In particular, anticancer and antibacterial agents could take advantage of such therapeutic strategy. We ha...

of 3